Vann Equity Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Vann Equity Management's ABBV Position: Q3 2026 in Review
Vann Equity Management reduced its AbbVie (ABBV) stake by 6.5% in Q3 2026, selling an estimated $92.5K and leaving 5,180 shares worth $1.36M. The position accounts for 0.81% of the portfolio, ranked #28.
Vann Equity Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.39M in Q2 2026. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Vann Equity Management held 5,180 shares of AbbVie worth $1.36M as of Q3 2026.
- Vann Equity Management sold 361 AbbVie shares in Q3 2026, an estimated $92.5K.
- AbbVie made up 0.81% of Vann Equity Management's portfolio in Q3 2026, its #28 holding.
- Vann Equity Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
- Vann Equity Management's AbbVie position peaked at $1.39M in Q2 2026.
- 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Vann Equity Management's 13F filing for Q3 2026, filed 8 Oct 2026.